Stoke Therapeutics, Inc. (STOK) › Operating Cash FlowStoke Therapeutics, Inc. (STOK) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$10.96M2019: -$31.05M2020: -$42.22M2021: -$66.91M2022: -$31.87M2023: -$81.07M2024: -$86.85M2025: $45.59M$45.59M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$45.59M+152.5%2024-$86.85M-7.1%2023-$81.07M-154.4%2022-$31.87M+52.4%2021-$66.91M-58.5%2020-$42.22M-36.0%2019-$31.05M-183.2%2018-$10.96M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share